# Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

> **NCT03720392** · PHASE2 · TERMINATED · sponsor: **Zachariah Michael DeFilipp** · enrollment: 8 (actual)

## Conditions studied

- Allogeneic Hematopoietic Cell Transplantation (HCT)

## Interventions

- **DRUG:** FMT
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03720392
- **Lead sponsor:** Zachariah Michael DeFilipp
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-15
- **Primary completion:** 2020-05-28
- **Final completion:** 2020-05-28
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Terminated due to sponsor decision
- **Last updated:** 2021-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03720392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03720392, "Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03720392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*